<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">Inflammation has been implicated in the pathogenesis of COVID-19. It is a physiological/defense response of the host to harmful stimuli such as pathogenic infections, allergens, chemical toxicity or injury to the tissues. If left uncontrolled, inflammatory response can results into deleterious effects such as cancer, cardiovascular dysfunctions, autoimmune diseases and metabolic syndrome (
 <xref rid="bib22" ref-type="bibr">Bagad et al., 2013</xref>). Modern medicines like non-steroid anti-inflammatory drugs, steroids, and immunosuppressant have been used to control and suppress inflammatory diseases but with associated unwanted side effects. Thus, the need for natural anti-inflammatory agents with increased pharmacological response and no or lowest degree of adverse effects (
 <xref rid="bib22" ref-type="bibr">Bagad et al., 2013</xref>; 
 <xref rid="bib159" ref-type="bibr">Oladele et al., 2017</xref>) which is obtainable in medicinal plants. 
 <italic>Curcuma longa</italic> (Turmeric) is one of such medicinal plant, the most essential metabolite of turmeric is curcumin and its responsible for its anti-inflammatory properties (
 <xref rid="bib100" ref-type="bibr">Jurenka, 2009</xref>; 
 <xref rid="bib160" ref-type="bibr">Oladele et al., 2020a</xref>). Many clinical studies have been carried out to prove the anti-inflammatory effect of curcumin in diseases such as rheumatoid arthritis and reduced its clinical manifestation such as joint swelling and morning stiffness when compare with standard drug, phenylbutazone (
 <xref rid="bib62" ref-type="bibr">Deodhar et al., 1980</xref>). Curcumin also offers beneficial effects in treatment of ulcerative colitis (
 <xref rid="bib86" ref-type="bibr">Hanai et al., 2006</xref>), irritable bowel syndrome (IBS) (
 <xref rid="bib35" ref-type="bibr">Bundy et al., 2004</xref>), psoriasis (by the selective prohibition of phosphorylase kinase) (
 <xref rid="bib88" ref-type="bibr">Heng et al., 2000</xref>) and act as a reducing agent to delayed graft rejection (DGR) after kidney transplant surgery (
 <xref rid="bib202" ref-type="bibr">Shoskes et al., 2005</xref>).
</p>
